CTLA4 and renal cell carcinoma: On the other hand, Wang et al. demonstrated that RCC tumors with high expression of stemness-related genes exhibited increased sensitivity to anti-CTLA-4 therapy, which was accompanied by a suppression of stemness features [65, 161].